Cardiogen 20 mg

Technical Details

Dosage & Usage Guidelines

Cardiogen 20 mg is used in studies exploring:

• Myocardial tissue regeneration
• Endothelial healing after ischemia
• Cardiac fibrosis reduction
• Enhanced angiogenesis in the heart and vasculature

Its potential extends to metabolic cardiology protocols, often in synergy with insulin-sensitizing agents or inflammation regulators. In some research setups, it's stacked with ARA-290 and BPC-157 for broader cardiovascular protection and recovery.

Suggested Experimental Use

• Dose: 10–20 mg per day
• Route: Subcutaneous injection (or intraperitoneal in animal models)
• Cycle: 7–28 days depending on severity of cardiac event or vascular insult

Stacking Options

For comprehensive heart and vascular recovery, Cardiogen is often combined in studies with:

• GHK-CU – reduces scar formation and supports angiogenesis
• Semax – for neurovascular recovery and anti-inflammatory action
• AOD 9604 – to aid metabolic recovery and fat mobilization post-cardiac trauma

Safety Profile

Cardiogen is not associated with androgenic, estrogenic, or hepatotoxic effects. It does not aromatize or elevate blood pressure and is considered well-tolerated in preclinical testing. Side effects are rare, limited to mild site irritation or temporary fatigue in some cases.

Legal Disclaimer

Cardiogen is not FDA-approved and is intended for research purposes only. It must not be used for human consumption. For ongoing studies and cardiovascular-related peptide protocols, visit ClinicalTrials.gov.

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions